Senior Medical Oncologist Lung

Chicago, Illinois
Competitive salary and benefits
May 17, 2018
Jul 15, 2018
Career Fair Category
Career Fair

The Division of Hematology, Oncology and Cell Therapy in the Department of Medicine at Rush University Medical is recruiting a Senior Medical Oncologist with interest in lung oncology at the associate or professor level.  The successful candidate will be board certified in medical oncology and have demonstrated leadership in the field of Thoracic Oncology on a national level.  The successful candidate will have a Co-Directorship in a well-developed multidisciplinary program that includes at least 3 full-time dedicated thoracic oncologists, 5 full-time thoracic surgeons and a full-time radiation oncologist all dedicated to lung cancer and other chest malignancies. The predominant criteria include: a major commitment to research and scholarly activity that advances the field of medicine, teaching, excellence in clinical care, and institutional service appropriate to the programmatic need the individual is expected to fulfill.

The thoracic oncology program at Rush currently provides care for the largest number of lung cancer patients in the Chicagoland area.  The program boasts a clinical database and tumor/serum bank of over 4,000 patients with NIH funded translational research. Medical oncologists at Rush continue to participate year after year in multicenter trials of several immunotherapies for advanced and early-stage lung cancers. Rush researchers have been involved in early studies that lead to the approval of erlotinib, and continue to offer clinical trials testing the latest targeted therapies in solid tumors. Rush is one of only six medical centers in the country to partner with Tempus, a Chicago-based technology company using genomic mapping that will enable clinicians around the world to customize more effective treatments. The International Association for the Study of Lung Cancer (IASLC) chose Rush's lung cancer care team as one of only five worldwide recipients — one of two in North America — of the foundation's inaugural Cancer Care Team Award in 2017. Acknowledging cancer care teams across the globe who go above and beyond to provide the highest-quality patient care, the award is unique in that the recipients were nominated by patients.

Our new, state-of-the-art Cancer Center facility in Chicago will serve as a hub for services throughout our health system. Our core programs are supported by multi-disciplinary teams from medical oncology, surgical oncology, radiation oncology, pathology, radiology, research and bioinformatics, clinical operations, and dedicated clinical and support staff, including patient navigators. This structure allows specialists to more easily consult and see patients based on tumor type or molecular and genomic signatures, combining our outstanding multidisciplinary approach with a data infrastructure that supports this patient-centered care. This integration enables us to make a greater commitment to research, dramatically scaling the effectiveness of clinical trials, and enabling translational research that moves bench to bedside, and bedside to bench.

Rush University Medical Center is consistently ranked as one of the nation’s top hospitals by U.S. News & World Report. Rush is ranked in 8 of 16 categories in U.S. News & World Report's 2016-2017 "America's Best Hospital's" issue, and is one of the two top-ranked hospitals in Illinois overall. Rush was one of four hospitals in the country that the American Hospital Association honored for equity of care in June of 2017. Rush was the first hospital in Illinois serving adults and children to receive Magnet status – the highest honor in nursing – and the first in Illinois to earn a fourth four-year designation. Rush has been ranked among the country's top 100 hospitals — and 15 major teaching hospitals — four times by Truven Health Analytics, a leading provider of health care data and analytics. Rush is located short distances from two other universities, two other medical centers, transportation centers, sports facilities, and residential/shopping neighborhoods.

Interested candidates, please address your CV and cover letter to:

Timothy M. Kuzel, MD, FACP
Chief, Division of Hematology, Oncology and Cell Therapy and
Professor of Medicine
Rush University Medical Center

Via email to: Rose Sprinkle, Manager, Faculty Recruitment at: